Doc­tors With­out Bor­ders re­jects Vi­iV Health­care's pro­posed con­tract for long-act­ing HIV PrEP drug

Med­ical ad­vo­ca­cy group Médecins Sans Fron­tières (MSF), al­so known as Doc­tors With­out Bor­ders, called up­on Vi­iV Health­care Thurs­day to cut a con­fi­den­tial­i­ty clause and re­vise sup­ply terms in a pro­posed pur­chase agree­ment for Vi­iV’s long-act­ing form of HIV drug cabote­gravir.

MSF said it placed a pur­chase or­der for the drug in Ju­ly 2022, af­ter FDA ap­proved the ex­tend­ed-re­lease ver­sion in Dec. 2021. MSF said that it be­gan good-faith ne­go­ti­a­tions with Vi­iV at that time to fi­nal­ize a re­quired pur­chase con­tract but af­ter months of ne­go­ti­a­tions, MSF said Vi­iV in­tro­duced “last-minute changes” to the agree­ment in May, which the or­ga­ni­za­tion said were not in line with oth­er agree­ments with man­u­fac­tur­ers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER